Literature DB >> 18790456

Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.

Kirsten M Williams1, Ronald E Gress.   

Abstract

Recovery of a fully functional immune system is a slow and often incomplete process following allogeneic stem cell transplantation. While innate immunity reconstitutes quickly, adaptive B- and especially T-cell lymphopoeisis may be compromised for years following transplantation. In large part, these immune system deficits are due to the decrease, or even absence, of thymopoiesis following transplantation. Thereby, T-cell reconstitution initially relies upon expansion of mature donor T cells; a proliferation driven by high cytokine levels and the presence of allo-reactive antigens. This peripheral mechanism of T-cell generation may have important clinical consequences. By expanding tumouricidal T cells, it may provide a venue to enhance T-cellular immunotherapy following transplantation. Alternatively, decreased thymic function may impair long-term anti-tumour immunity and increase the likelihood of graft-versus-host disease.

Entities:  

Mesh:

Year:  2008        PMID: 18790456      PMCID: PMC2577193          DOI: 10.1016/j.beha.2008.06.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  136 in total

1.  T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.

Authors:  B C Godthelp; M J van Tol; J M Vossen; P J van Den Elsen
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

3.  T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny.

Authors:  C L Mackall; L Granger; M A Sheard; R Cepeda; R E Gress
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

4.  Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest.

Authors:  I Suzuki; E C Milner; A M Glas; W O Hufnagle; S P Rao; L Pfister; C Nottenburg
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

5.  Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing.

Authors:  C L Mackall; C V Bare; L A Granger; S O Sharrow; J A Titus; R E Gress
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

6.  Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice.

Authors:  Philip J Lucas; Seong-Jin Kim; Crystal L Mackall; William G Telford; Yu-Waye Chu; Frances T Hakim; Ronald E Gress
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

7.  Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.

Authors:  E Bolotin; M Smogorzewska; S Smith; M Widmer; K Weinberg
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

8.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

Authors:  C L Mackall; T A Fleisher; M R Brown; M P Andrich; C C Chen; I M Feuerstein; M E Horowitz; I T Magrath; A T Shad; S M Steinberg
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

9.  B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?

Authors:  J Storek; S Ferrara; N Ku; J V Giorgi; R E Champlin; A Saxon
Journal:  Bone Marrow Transplant       Date:  1993-10       Impact factor: 5.483

10.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  39 in total

1.  Nasal Wash Cytokines during Respiratory Viral Infection in Pediatric Allogeneic Hematopoietic Cell-Transplant Recipients.

Authors:  Tim Flerlage; Aisha Souquette; E Kaitlynn Allen; Timothy Brahm; Jeremy Chase Crawford; Li Tang; Yilun Sun; Gabriela Maron; Joshua Wolf; Brandon Triplett; Paul G Thomas
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

2.  Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Christine M Hartford; Deqing Pei; Meredith J Posner; Jie Yang; Randall T Hayden; Ashok Srinivasan; Brandon M Triplett; Jon A McCulllers; Ching-Hon Pui; Wing Leung
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

3.  Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells.

Authors:  A Barber; K R Meehan; C L Sentman
Journal:  Gene Ther       Date:  2011-01-06       Impact factor: 5.250

4.  Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion.

Authors:  Pavan Bachireddy; Ursula Hainz; Michael Rooney; Olga Pozdnyakova; Julie Aldridge; Wandi Zhang; Xiaoyun Liao; F Stephen Hodi; Karyn O'Connell; W Nicholas Haining; Natalie R Goldstein; Christine M Canning; Robert J Soiffer; Jerome Ritz; Nir Hacohen; Edwin P Alyea; Haesook T Kim; Catherine J Wu
Journal:  Blood       Date:  2013-12-19       Impact factor: 22.113

5.  Real Time Immunophenotyping of Leukocyte Subsets Early after Double Cord Blood Transplantation Predicts Graft Function.

Authors:  Jianqiang Li; Ian Nicoud; Joseph Blake; David Oliver; Emily Cox; Shelly Heimfeld; Filippo Milano; Suzan Imren; Colleen Delaney
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-19       Impact factor: 5.742

6.  Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation.

Authors:  Nannan Pang; Jianli Xu; Jianhua Qu; Xianlin Duan; Hailong Yuan; Gang Chen; Ming Jiang; Jianbing Ding
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 7.  Immunologic approaches for the treatment of multiple myeloma.

Authors:  Leo Rasche; Niels Weinhold; Gareth J Morgan; Frits van Rhee; Faith E Davies
Journal:  Cancer Treat Rev       Date:  2017-04-06       Impact factor: 12.111

8.  Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  Xinmiao Jiang; Lanping Xu; Yu Zhang; Fen Huang; Daihong Liu; Jin Sun; Chaoyang Song; Xinquan Liang; Zhiping Fan; Hongsheng Zhou; Min Dai; Can Liu; Qianli Jiang; Na Xu; Li Xuan; Meiqing Wu; Xiaojun Huang; Qifa Liu
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

9.  Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.

Authors:  Amorette Barber; Charles L Sentman
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

10.  Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation.

Authors:  Julie Lang; Margot Kelly; Brian M Freed; Martin D McCarter; Ross M Kedl; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.